Vasculitis treatment – new therapeutic approaches
- 9 March 2006
- journal article
- review article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 165 (6) , 351-357
Abstract
In childhood, vasculitis carries with it a not inconsequential morbidity and mortality. Current therapy is usually effective in inducing remission, but there is a penalty in terms of significant and serious side effects as well as concerns about long-term maintenance regimens. Additionally, some patients are recalcitrant to treatment and options have, hitherto, been limited in relation to alternative therapy. In view of this, novel therapeutic approaches are being explored that include the better use of long-established agents as well as the utilization of newer immunosuppressive and immunomodulatory strategies. Blockade of circulating mediators and surface receptors as well as lymphocyte depletion and immunoablation are being introduced predominantly in adults but increasingly also in children. With greater understanding of the pathogenetic mechanisms involved in the disease processes it is becoming possible to utilize much more focussed therapy for these serious and life-threatening disorders with, hopefully, a decrease in long-term morbidity and mortality as well as a diminution of drug-induced adverse effects.Keywords
This publication has 83 references indexed in Scilit:
- What is new in the therapy of ANCA- associated vasculitides?Take home messages from the 12th workshop on ANCA and systemic vasculitidesClinical Nephrology, 2005
- Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patientsNephrology Dialysis Transplantation, 2005
- Retrospective study of plasma exchange in children with systemic lupus erythematosusPediatric Nephrology, 2004
- Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis. How long? How much?Pediatric Nephrology, 2004
- Plasmapheresis therapy for rapidly progressive Henoch-Sch nlein nephritisPediatric Nephrology, 2004
- Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: rapid response to rituximabJournal of the American Academy of Dermatology, 2003
- Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodiesQJM: An International Journal of Medicine, 1996
- Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroidsThe Journal of Pediatrics, 1996
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992
- Cyclophosphamide Therapy of Severe Systemic Necrotizing VasculitisNew England Journal of Medicine, 1979